IQVIA Holdings Inc (IQV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IQVIA Holdings Inc (IQV) has a cash flow conversion efficiency ratio of 0.408x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.65 Billion) by net assets ($6.50 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of IQVIA Holdings Inc to measure how many days the company can operate on defensive assets alone.
IQVIA Holdings Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how IQVIA Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
IQVIA Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IQVIA Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Talanx AG
XETRA:TLX
|
0.183x |
|
TRIP.COM GROUP DL-00125
F:CLVB
|
N/A |
|
TDK Corporation
F:TDKA
|
0.059x |
|
Otis Worldwide Corp
NYSE:OTIS
|
-0.071x |
|
Atmos Energy Corporation
NYSE:ATO
|
0.025x |
|
Chunghwa Telecom Co. Ltd
F:CHWD
|
0.080x |
|
FTAI Aviation Ltd.
NASDAQ:FTAI
|
-0.536x |
|
VICI Properties Inc
NYSE:VICI
|
0.022x |
Annual Cash Flow Conversion Efficiency for IQVIA Holdings Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of IQVIA Holdings Inc from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see IQV market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $6.63 Billion | $2.65 Billion | 0.400x | -10.58% |
| 2024-12-31 | $6.07 Billion | $2.72 Billion | 0.448x | +27.32% |
| 2023-12-31 | $6.11 Billion | $2.15 Billion | 0.352x | -10.31% |
| 2022-12-31 | $5.76 Billion | $2.26 Billion | 0.392x | -19.49% |
| 2021-12-31 | $6.04 Billion | $2.94 Billion | 0.487x | +56.09% |
| 2020-12-31 | $6.28 Billion | $1.96 Billion | 0.312x | +37.88% |
| 2019-12-31 | $6.26 Billion | $1.42 Billion | 0.226x | +25.47% |
| 2018-12-31 | $6.95 Billion | $1.25 Billion | 0.180x | +55.38% |
| 2017-12-31 | $8.36 Billion | $970.00 Million | 0.116x | +19.57% |
| 2016-12-31 | $8.86 Billion | $860.00 Million | 0.097x | +106.85% |
| 2015-12-31 | $-335.68 Million | $475.69 Million | -1.417x | -131.07% |
| 2014-12-31 | $-704.01 Million | $431.75 Million | -0.613x | -3.02% |
| 2013-12-31 | $-667.49 Million | $397.37 Million | -0.595x | -141.01% |
| 2012-12-31 | $-1.36 Billion | $335.70 Million | -0.247x | -48.80% |
| 2011-12-31 | $-969.60 Million | $160.95 Million | -0.166x | -- |
About IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more